Literature DB >> 1746964

Kinetics of Saccharomyces cerevisiae elimination from the intestines of human volunteers and effect of this yeast on resistance to microbial colonization in gnotobiotic mice.

S Pecquet1, D Guillaumin, C Tancrede, A Andremont.   

Abstract

When healthy volunteers were given a daily dose of 3 x 10(8) life-dehydrated Saccharomyces cerevisiae cells for 5 days, the volunteers excreted 10(5) living yeast cells per g of feces at first, but the yeast cells disappeared within 5 days of the end of treatment. In gnotobiotic mice, S. cerevisiae administered alone colonized the intestinal tract but did not interfere with previous or subsequent colonization by a variety of potentially enteropathogenic microorganisms. When these microorganisms were present, the intestinal counts of S. cerevisiae were greatly reduced.

Entities:  

Mesh:

Year:  1991        PMID: 1746964      PMCID: PMC183921          DOI: 10.1128/aem.57.10.3049-3051.1991

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  16 in total

1.  Effects of roxithromycin on fecal bacteria in human volunteers and resistance to colonization in gnotobiotic mice.

Authors:  S Pecquet; E Chachaty; C Tancrède; A Andremont
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii.

Authors:  J P Buts; P Bernasconi; M P Van Craynest; P Maldague; R De Meyer
Journal:  Pediatr Res       Date:  1986-02       Impact factor: 3.756

3.  Enzyme-substitution therapy with the yeast Saccharomyces cerevisiae in congenital sucrase-isomaltase deficiency.

Authors:  H K Harms; R M Bertele-Harms; D Bruer-Kleis
Journal:  N Engl J Med       Date:  1987-05-21       Impact factor: 91.245

4.  [Treatment of acute infantile diarrhea: controlled trial of Saccharomyces boulardii].

Authors:  P Chapoy
Journal:  Ann Pediatr (Paris)       Date:  1985-06

5.  [Transit through the digestive tract of the inocula of several bacterial strains introduced "per Os" into axenic and "Holoxenic" mice. The antagonistic effect of the microflora of the gastrointestinal tract].

Authors:  R Ducluzeau; M Bellier; P Raibaud
Journal:  Zentralbl Bakteriol Orig       Date:  1970-05

6.  Enhancement of resistance to infectious diseases by oral administration of brewer's yeast.

Authors:  Y Sinai; A Kaplun; Y Hai; B Halperin
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

7.  Prevention of Clostridium difficile induced mortality in gnotobiotic mice by Saccharomyces boulardii.

Authors:  G Corthier; F Dubos; R Ducluzeau
Journal:  Can J Microbiol       Date:  1986-11       Impact factor: 2.419

8.  Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study.

Authors:  C M Surawicz; G W Elmer; P Speelman; L V McFarland; J Chinn; G van Belle
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

9.  [Influence of Saccharomyces boulardii on jejunal secretion in rats induced by cholera toxin].

Authors:  N Vidon; B Huchet; J C Rambaud
Journal:  Gastroenterol Clin Biol       Date:  1986-01

10.  Prevention of clindamycin-induced mortality in hamsters by Saccharomyces boulardii.

Authors:  R D Toothaker; G W Elmer
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

View more
  10 in total

Review 1.  Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2010-05-14       Impact factor: 5.742

2.  Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans.

Authors:  Stéphanie Blanquet-Diot; Sylvain Denis; Sandrine Chalancon; Fehd Chaira; Jean-Michel Cardot; Monique Alric
Journal:  Pharm Res       Date:  2011-11-09       Impact factor: 4.200

3.  Yeasts from kefir grains: isolation, identification, and probiotic characterization.

Authors:  Gabriela Diosma; David E Romanin; María F Rey-Burusco; Alejandra Londero; Graciela L Garrote
Journal:  World J Microbiol Biotechnol       Date:  2013-07-04       Impact factor: 3.312

4.  Genotypic and physiological characterization of Saccharomyces boulardii, the probiotic strain of Saccharomyces cerevisiae.

Authors:  Laura Edwards-Ingram; Paul Gitsham; Nicola Burton; Geoff Warhurst; Ian Clarke; David Hoyle; Stephen G Oliver; Lubomira Stateva
Journal:  Appl Environ Microbiol       Date:  2007-02-09       Impact factor: 4.792

5.  Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers.

Authors:  S M Klein; G W Elmer; L V McFarland; C M Surawicz; R H Levy
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

6.  Recombinant Saccharomyces cerevisiae expressing P450 in artificial digestive systems: a model for biodetoxication in the human digestive environment.

Authors:  S Blanquet; J P Meunier; M Minekus; S Marol-Bonnin; M Alric
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

7.  Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota.

Authors:  Jonathan Thévenot; Lucie Etienne-Mesmin; Sylvain Denis; Sandrine Chalancon; Monique Alric; Valérie Livrelli; Stéphanie Blanquet-Diot
Journal:  Appl Environ Microbiol       Date:  2012-11-30       Impact factor: 4.792

8.  Recombinant Saccharomyces cerevisiae strain expressing a model cytochrome P450 in the rat digestive environment: viability and bioconversion activity.

Authors:  G Garrait; J F Jarrige; S Blanquet; E Beyssac; M Alric
Journal:  Appl Environ Microbiol       Date:  2007-04-06       Impact factor: 4.792

9.  S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death.

Authors:  Vincent Cascio; Daniel Gittings; Kristen Merloni; Matthew Hurton; David Laprade; Nicanor Austriaco
Journal:  BMC Microbiol       Date:  2013-02-13       Impact factor: 3.605

10.  Dynamic In Vitro Models of the Human Gastrointestinal Tract as Relevant Tools to Assess the Survival of Probiotic Strains and Their Interactions with Gut Microbiota.

Authors:  Charlotte Cordonnier; Jonathan Thévenot; Lucie Etienne-Mesmin; Sylvain Denis; Monique Alric; Valérie Livrelli; Stéphanie Blanquet-Diot
Journal:  Microorganisms       Date:  2015-10-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.